New Study Examines Serum Neuromedin U Levels in Type 1 and Type 2 Diabetics

Strategic Insights -

Investigations into serum Neuromedin U (NmU) levels in patients with Type 1 (T1DM) and Type 2 diabetes mellitus (T2DM) have yielded new findings, indicating a lack of significant difference between diabetic patients and healthy controls. The study, conducted by researchers at Bursa Uludag University, involved 134 participants across three groups: 45 with T1DM, 49 with T2DM, and 40 healthy controls. The research aimed to assess the correlation between NmU levels and body mass index (BMI) in these groups.

Key Takeaways:

  • The study involved 134 participants across three groups: 45 with T1DM, 49 with T2DM, and 40 healthy controls.
  • Serum NmU levels were measured using enzyme-linked immunosorbent assay (ELISA), and the correlation with BMI was assessed.
  • No significant correlation was observed between NmU and BMI in T1DM or T2DM groups, whereas the healthy control group found a significant inverse correlation between NmU and BMI (rho=-0.373, p<0.005).
  • The study is the first to compare NmU levels across diabetic subtypes, providing novel insights into the role of NmU in metabolic homeostasis.
  • The research was peer-reviewed and published in the journal Endocrinologia, Diabetes y Nutricion.
  • The study's findings may have implications for understanding the role of NmU in diabetes management and metabolic regulation.

Statistics:

  • The study involved 134 participants across three groups: 45 with T1DM, 49 with T2DM, and 40 healthy controls.
  • The correlation coefficient between NmU and BMI in the healthy control group was rho=-0.373 (p<0.005).
  • The study found that NmU levels were not significantly different between diabetic patients and healthy controls.
  • The study provides the first comparison of NmU levels across diabetic subtypes.

Sources:

  • Neuromedin U and BMI correlation in T1DM and T2DM vs healthy controls: A comparative study. Endocrinologia, Diabetes y Nutricion, 2025;72(8):501631.
  • NewsRx. New Science Study Findings Recently Were Reported by Researchers at Bursa Uludag University (Neuromedin U and BMI correlation in T1DM and T2DM vs healthy controls: A comparative study). Diabetes Week. October 20, 2025; p 368.